These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7272149

  • 21. A test for the assessment of the duration of the action of neostigmine and of the relative potencies of various anticholinesterases using the pupil of the mouse.
    Schneider R.
    J Pharm Pharmacol; 1970 Apr; 22(4):298-301. PubMed ID: 4392572
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cholinesterase inhibitors in myasthenia gravis.
    Lange MJ.
    Practitioner; 1966 Mar; 196(173):448-53. PubMed ID: 5905423
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Comparison between the hypertensive activity and anticholinesterase activity of neostigmine].
    Siro-Brigiani G, Chieppa D.
    Arch Ital Sci Farmacol; 1965 Mar; 15(3):164-7. PubMed ID: 5877518
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A study of the interaction between oxytetracycline and pyridostigmine.
    Johnston A, Hedges A, Turner P.
    Hum Toxicol; 1988 May; 7(3):263-6. PubMed ID: 3391624
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Duration of action of neostigmine and pyridostigmine in the elderly.
    Young WL, Matteo RS, Ornstein E.
    Anesth Analg; 1988 Aug; 67(8):775-8. PubMed ID: 3394965
    [Abstract] [Full Text] [Related]

  • 37. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK, Haigh JR, Garcia GE, Feaster SR, Riel MA, Lenz DE, Aisen PS, Doctor BP.
    Chem Biol Interact; 2005 Dec 15; 157-158():239-46. PubMed ID: 16256090
    [Abstract] [Full Text] [Related]

  • 38. Suxamethonium-neostigmine interaction in patients with normal or atypical cholinesterase.
    Baraka A.
    Br J Anaesth; 1977 May 15; 49(5):479-84. PubMed ID: 861116
    [Abstract] [Full Text] [Related]

  • 39. Stress interacts with peripheral cholinesterase inhibitors to cause central nervous system effects.
    Beck KD, Brennan FX, Moldow RL, Ottenweller JE, Zhu G, Servatius RJ.
    Life Sci; 2003 May 23; 73(1):41-51. PubMed ID: 12726885
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.